PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Sloan Ratio % : -1.31% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is PT Industri Jamu dan Farmasi Sido Muncul Tbk Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Sloan Ratio for the quarter that ended in Mar. 2024 was -1.31%.

As of Mar. 2024, PT Industri Jamu dan Farmasi Sido Muncul Tbk has a Sloan Ratio of -1.31%, indicating the company is in the safe zone and there is no funny business with accruals.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Sloan Ratio % Historical Data

The historical data trend for PT Industri Jamu dan Farmasi Sido Muncul Tbk's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Sloan Ratio % Chart

PT Industri Jamu dan Farmasi Sido Muncul Tbk Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Sloan Ratio %

Get a 7-Day Free Trial

3.03

-0.17

4.57

4.34

-1.48

PT Industri Jamu dan Farmasi Sido Muncul Tbk Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Sloan Ratio %	Get a 7-Day Free Trial															3.90	4.29	-1.81	-1.48	-1.31

Competitive Comparison of PT Industri Jamu dan Farmasi Sido Muncul Tbk's Sloan Ratio %

For the Drug Manufacturers - Specialty & Generic subindustry, PT Industri Jamu dan Farmasi Sido Muncul Tbk's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Sloan Ratio % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Industri Jamu dan Farmasi Sido Muncul Tbk's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where PT Industri Jamu dan Farmasi Sido Muncul Tbk's Sloan Ratio % falls into.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio	=	(Net Income (A: Dec. 2023 )	-	Cash Flow from Operations (A: Dec. 2023 )
	-	Cash Flow from Investing (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2023 )
	=	(950648	-	1055394
	-	-46993)	/	3890706
	=	-1.48%

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio	=	(Net Income (TTM)	-	Cash Flow from Operations (TTM))
	-	Cash Flow from Investing (TTM))	/	Total Assets (Q: Mar. 2024 )
	=	(1040862	-	1136812
	-	-40198)	/	4252874
	=	-1.31%

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was 147828 (Jun. 2023 ) + 138466 (Sep. 2023 ) + 364075 (Dec. 2023 ) + 390493 (Mar. 2024 ) = Rp1,040,862 Mil.
PT Industri Jamu dan Farmasi Sido Muncul Tbk's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was 52940 (Jun. 2023 ) + 359431 (Sep. 2023 ) + 441478 (Dec. 2023 ) + 282963 (Mar. 2024 ) = Rp1,136,812 Mil.
PT Industri Jamu dan Farmasi Sido Muncul Tbk's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was -10188 (Jun. 2023 ) + -16698 (Sep. 2023 ) + 502 (Dec. 2023 ) + -13814 (Mar. 2024 ) = Rp-40,198 Mil.

PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, PT Industri Jamu dan Farmasi Sido Muncul Tbk has a Sloan Ratio of -1.31%, indicating the company is in the safe zone and there is no funny business with accruals.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of PT Industri Jamu dan Farmasi Sido Muncul Tbk's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) » Definitions » Sloan Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Gajahmada No. 123, 1st Floor, Gedung Hotel Tentrem, Office Sido Muncul, Lantai 1, Semarang, IDN, 50134

Website

https://www.sidomuncul.co.id

PT Industri Jamu dan Farmasi Sido Muncul Tbk is biotechnology company that provides herbal medicine and pharmaceutical products. The company has three business segments, Herbal Medicine, Food and Beverage, and Pharmacy. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionary products. The Pharmacy segment sells pharmaceutical products such as Anacetine, a fever reducer, Berlosid, a medicine to reduce gastric pain, and Combicitrine, a medicine for bacterial removal. The company generates the majority of its revenue in Indonesia.

PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Headlines

No Headlines